UCL Great Ormond Street Institute of Child Health, 30 Guilford Street, London WC1N 1EH, UK; Great Ormond Street Hospital for Children, Great Ormond St, London WC1N 3JH, UK.
UCL Great Ormond Street Institute of Child Health, 30 Guilford Street, London WC1N 1EH, UK.
Seizure. 2024 Oct;121:78-84. doi: 10.1016/j.seizure.2024.08.005. Epub 2024 Aug 5.
There is limited research on the proportion of individuals with epilepsy who maintain response to ketogenic diet therapy (KDT) after discontinuing treatment. We aimed to determine the proportion of individuals who did / did not maintain response post KDT and explore factors that may influence the likelihood of maintaining response.
Retrospective data were collected from 97 individuals from 9 KDT centres. Individuals had achieved ≥50 % seizure reduction on KDT for at least 12 months, with seizure frequency data available at 3 months+ post diet. Outcome 1 was: recurrence of seizures or increase in seizure frequency post diet; outcome 2: recurrence of seizures, increase in seizure frequency or an additional anti-seizure treatment started post diet.
61/97 (62.9 %) individuals maintained response at latest follow-up (mean 2.5[2.0] years since stopping KDT). Approximately one third maintained response without further anti-seizure treatments. One quarter of individuals had an increase in frequency or recurrence of seizures within 6 months (95 %CI 4, 12) for outcome 1 and within 3 months (3, 6) for outcome 2. Individuals who did not achieve seizure freedom on diet were significantly more likely to have an increase in seizures or to require additional anti-seizure treatments post diet compared to those who were seizure-free on diet (hazard ratio 4.02, 95 %CI (1.46, 11.16) p < 0.01).
Our findings should help guide clinical teams with the information they provide patients and their families regarding likelihood of long-term seizure response to KDT. Realistic costings for KDT services may need to be considered.
关于停止 ketogenic 饮食疗法 (KDT) 后仍能保持疗效的癫痫患者比例,相关研究较少。本研究旨在确定 KDT 后停止治疗仍能保持疗效的个体比例,并探讨可能影响疗效维持可能性的因素。
从 9 个 KDT 中心收集了 97 名个体的回顾性数据。个体在 KDT 治疗至少 12 个月后达到了 ≥50%的癫痫发作减少率,并且在饮食后 3 个月+可获得癫痫发作频率数据。主要结局 1 为:饮食后癫痫发作复发或频率增加;次要结局 2:饮食后癫痫发作复发、频率增加或开始使用额外的抗癫痫药物。
97 名个体中,61/97(62.9%)在最近一次随访时保持疗效(停止 KDT 后平均 2.5[2.0]年)。约三分之一的个体无需进一步抗癫痫治疗即可保持疗效。大约四分之一的个体在 6 个月(95%CI 4,12)内(结局 1)或 3 个月(3,6)内(结局 2)出现了癫痫发作频率增加或复发。与饮食后无癫痫发作的个体相比,饮食后未达到无癫痫发作的个体更有可能出现癫痫发作增加或需要额外的抗癫痫治疗(风险比 4.02,95%CI(1.46,11.16),p<0.01)。
我们的研究结果有助于指导临床团队向患者及其家属提供有关 KDT 长期癫痫反应可能性的信息。可能需要考虑 KDT 服务的实际成本。